Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy with blood products].

S Petros1

  • 1Interdisziplinäre Internistische Intensivmedizin, Zentrum für Hämostaseologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland. sirak.petros@medizin.uni-leipzig.de.

Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|January 31, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early in-hospital course of critically ill nontrauma patients in a resuscitation room of a German emergency department (OBSERvE2 study).

Die Anaesthesiologie·2021
Same author

[Clinical skills].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[Laboratory testing in intensive care medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients.

European journal of clinical pharmacology·2019
Same author

Inhibitor eradication in refractory acquired hemophilia with lenalidomide.

Annals of hematology·2019
Same author

[Ten key messages of the guidelines for family-centered care in intensive care medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2018
Same journal

[Modern therapy of pulmonary embolism with PERT and EKOS: an advantage also for in-hospital time?]

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Extracorporeal immunomodulation in sepsis : Role, limits, and perspectives of adjuvant blood purification therapies].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Invasive mechanical ventilation: indications and alternatives : Systematic evaluation of the evidence and recommendations for clinical practice from the S3 guidelines "invasive mechanical ventilation and the use of extracorporeal procedures in acute respiratory failure"].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Out-of-hospital cardiac arrest : Current recommendations along the chain of survival and patient management].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Videolaryngoscopic endotracheal intubation during out-of-hospital cardiac arrest from the perspective of paramedics : Training requirements and subjective procedural confidence-results of an anonymous cross-sectional survey].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[The Freiburg concept of the "Neurological Emergency Receiving Team (NERT)" : Concept for structuring of time-critical courses of action for patients with a predominant disability problem with an interdisciplinary and interprofessional emergency team in the nontraumatological resuscitation room].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
See all related articles

Critically ill patients often receive blood products without clear outcome benefits. A restrictive approach to transfusions, guided by evidence, is recommended for better patient care.

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Transfusion Medicine

Background:

  • Blood products are widely used in intensive care, but evidence for improved clinical outcomes is limited.
  • Current transfusion thresholds, such as a hemoglobin level of 7.0 g/dL for erythrocyte transfusion, lack robust outcome data.
  • The use of plasma and platelets requires careful consideration of clinical context and potential risks like hypervolemia.

Purpose of the Study:

  • To critically evaluate the evidence supporting the use of various blood products in intensive care.
  • To advocate for a restrictive transfusion strategy based on a thorough appraisal of available data.
  • To provide guidance on appropriate indications for erythrocyte, platelet, plasma, and albumin transfusions.

Main Methods:

Keywords:
Blood coagulation factorsBlood plateletsErythrocytesPlasmaSerum albumin

Related Experiment Videos

  • Review of existing literature and clinical evidence regarding blood product utilization in critically ill patients.
  • Analysis of transfusion triggers and indications for different blood components.
  • Evaluation of specific scenarios like warfarin reversal, massive paracentesis, hepatorenal syndrome, and sepsis.

    • Main Results:

    • Limited evidence supports routine erythrocyte transfusions above a hemoglobin level of 7.0 g/dL in non-bleeding critically ill patients.
    • Platelet transfusion decisions should be individualized based on thrombocytopenia cause and clinical status.
    • Prothrombin complex concentrates are superior to plasma for warfarin reversal; albumin shows benefits in specific conditions like hepatorenal syndrome and sepsis.

    Conclusions:

    • A restrictive strategy for blood product transfusion in intensive care is strongly favored.
    • Transfusion decisions must be based on a critical evaluation of evidence, patient condition, and potential risks.
    • Optimizing the use of blood products can lead to improved patient outcomes and resource management.